ArticlePloS one2022

An assessment of prevalence of Type 1 CFI rare variants in European AMD, and why lack of broader genetic data hinders development of new treatments and healthcare access.

Amy V Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.